BioSpace News Archive

ProtaGene GmbH, a leading global contract research organization focused on advanced analytics in biologics and cell and gene therapy, announced today the appointment of Raymond Kaiser, Ph.D., as Chief Executive Officer.

Apollo Medical Holdings, Inc. today announced that management will be presenting at the following virtual investor conferences.

Horizon Therapeutics plc (Nasdaq: HZNP), in collaboration with MIT Solve, a marketplace for social impact innovation, is proud to announce the winning solution of this year’s Horizon Prize: Patient-Driven Data Platform for Rare Disease by EB Research Partnership.

Azura Ophthalmics Ltd. , a clinical-stage biopharmaceutical company developing a new therapeutic class of Ophthalmic Keratolytics for ocular surface diseases, today announced the formation of its scientific advisory board (SAB).

AbCellera (Nasdaq: ABCL) today announced it has launched the second phase of its global headquarters expansion by breaking ground on its new facility in Vancouver, Canada.

Novocure (NASDAQ: NVCR) today announced the creation of its U.S. CNS (central nervous system) Cancers Franchise.

Press release – No. 6 / 2022 Zealand Pharma Announces Oral Presentation of Phase 2 Data for BI 456906 at the 58 th Annual Meeting of the European Association for the Study of Diabetes (EASD).

Entera Bio Ltd. today announced that it will host a key opinion leader (KOL) webinar on the company’s lead asset EB613, and its potential impact on the osteoporosis market on Wednesday, September 28, 2022 at 10:00am ET.

NKGen Biotech today announced a publication in the peer-reviewed Journal of Cancer Research and Cellular Therapeutics entitled “Durable responses using SNK01 autologous enhanced natural killer cells and pembrolizumab for chemotherapy-resistant advanced sarcoma: Case reports, review of literature, and future perspectives.”

The Lawrence J. Ellison Institute for Transformative Medicine announced the appointment of Dr. Reva Basho as the Institute’s new Director of the Women’s Cancer Program.